Author

Haley M. Meyer

Institutions: Mayo Clinic, Mayo Clinic Hospital

Observed institutions: Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic Hospital

OpenAlex ID: A5067247277

Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers

2024 · Reagan M. Barnett, Albert Jang, et al. · Communications Medicine · 15

Clinical outcomes of immune checkpoint inhibitor treatment in patients with classic cold tumors identified to have a high tumor mutational burden via ctDNA.

2023 · Reagan Barnett, Sree M Lanka, et al. · Journal of Clinical Oncology

Works count: 2

Citation count: 15

H-index: 1

I10-index: 1